E-News - May 2026
Alliance Research in the News
Highlighting the Impact of the Alliance Research
At the Alliance for Clinical Trials in Oncology, we love sharing stories that show what’s happening in cancer research right now. Whether it’s a new clinical trial, a scientific breakthrough, or the work of one of our dedicated investigators, we want people to see the progress being made, and the real humans behind it.
These stories help explain why clinical trials are so important for cancer care. They give providers information on research that could change the way they treat patients, and they help patients and their caregivers find studies that might offer new options. Most importantly, these articles raise awareness of our work and build trust in the people bringing new solutions to families.
By telling these stories publicly, we’re broadening awareness, encouraging collaboration, and helping move innovation forward. It all brings us closer to what we’re here to do: finding better treatments and better outcomes for everyone facing cancer.
Below are links to some of our recent media coverage.
Alliance trial awareness
Alliance trial targets vaginal health issues after breast cancer treatments
The Alliance is enrolling patients in a clinical trial aimed at helping women recover from vaginal side effects of breast cancer treatment. The REVITALIZE study (Alliance A221801) is evaluating whether laser therapy can reduce vaginal dryness associated with breast cancer treatment, a common and often distressing side effect experienced by many breast cancer survivors, reported Australia’s Oncology News. An Alliance news story was the source.
ERASur Alliance trial hits one-third accrual milestone
The Alliance A022101/ERASur (Evaluation of Resection or Ablation for Limited Metastatic Colorectal Cancer) study has reached a major enrollment milestone, with more than one-third of its targeted patients now accrued, reported First Word Pharma, OncoZine and Bioengineer. The news is based on an Alliance news release.
New Alliance trial studies targeted radiation approach after lung cancer surgery
The Alliance has launched a new clinical trial (Alliance A082402) to determine whether a more targeted approach to radiation therapy can help prevent lung cancer returning from returning after surgery, reported Bioengineer, Science News and Bright Surf. The stories are based on an Alliance news release.
Alliance ShortStop HER2 trial is enrolling now
Led by Adrienne Waks, MD, of the Dana-Farber Cancer Institute, Alliance A012303 (ShortStop HER2) is phase III clinical trial now open for enrollment. This study is evaluating whether people with early-stage HER2-positive breast cancer whose cancer is no longer detectable after treatment before surgery can safely receive less treatment following surgery while maintaining the same strong outcomes, reported OncoDaily and NewsBreak.
New Alliance study aims to improve uptake of genetic testing for colorectal cancer
The new Alliance trial (A212101) led by Frank Sinicrope, MD, of Mayo Clinic, aims to improve the use of genetic testing in colorectal cancer by evaluating strategies to increase germline genetic testing among at-risk family members of newly diagnosed patients, helping to identify individuals who may have inherited cancer risk and could benefit from earlier screening and prevention, reported Yahoo! News, Business Insider, Ad Hoc News, World Pharmaceutical Frontiers, Nasdaq News, Genome Web, and Pulse,
Alliance trial results
ASCO 2026 featured Alliance and Alliance Foundation Trials research
This year’s American Society of Clinical Oncology (ASCO) Annual Meeting featured numerous Alliance and Alliance Foundation Trials abstracts among those selected for presentation. Dozens of new outlets reported that many Alliance trial results presented could change treatment paradigms. They include OncLive, ASCO, Associated Press, The Miami Times, Killeen Daily Herald, First Word Pharma, International Business Times, Benzinga, Stockwatch, Pulse, My Florida News, Investing.com and Yahoo! Finance.
E-News - May 2026
Spotlight on Alliance Research in the NewsE-News - June 2026
Spotlight on Alliance in the News
Alliance in the News in May: Highlighting the Impact of the Alliance Research
At the Alliance for Clinical Trials in Oncology, we love sharing stories that show what’s happening in cancer research right now. Whether it’s a new clinical trial, a scientific breakthrough, or the work of one of our dedicated investigators, we want people to see the progress being made, and the real humans behind it.
These stories help explain why clinical trials are so important for cancer care. They give providers information on research that could change the way they treat patients, and they help patients and their caregivers find studies that might offer new options. Most importantly, these articles raise awareness of our work and build trust in the people bringing new solutions to families.
By telling these stories publicly, we’re broadening awareness, encouraging collaboration, and helping move innovation forward. It all brings us closer to what we’re here to do: finding better treatments and better outcomes for everyone facing cancer.
Below are links to some of our recent media coverage.
Alliance trial awareness
Alliance trial targets vaginal health issues after breast cancer treatments
The Alliance is enrolling patients in a clinical trial aimed at helping women recover from vaginal side effects of breast cancer treatment. The REVITALIZE study (Alliance A221801) is evaluating whether laser therapy can reduce vaginal dryness associated with breast cancer treatment, a common and often distressing side effect experienced by many breast cancer survivors, reported Australia’s Oncology News. An Alliance news story was the source.
ERASur Alliance trial hits one-third accrual milestone
The Alliance A022101/ERASur (Evaluation of Resection or Ablation for Limited Metastatic Colorectal Cancer) study has reached a major enrollment milestone, with more than one-third of its targeted patients now accrued, reported First Word Pharma, OncoZine and Bioengineer. The news is based on an Alliance news release.
New Alliance trial studies targeted radiation approach after lung cancer surgery
The Alliance has launched a new clinical trial (Alliance A082402) to determine whether a more targeted approach to radiation therapy can help prevent lung cancer returning from returning after surgery, reported Bioengineer, Science News and Bright Surf. The stories are based on an Alliance news release.
Alliance ShortStop HER2 trial is enrolling now
Led by Adrienne Waks, MD, of the Dana-Farber Cancer Institute, Alliance A012303 (ShortStop HER2) is phase III clinical trial now open for enrollment. This study is evaluating whether people with early-stage HER2-positive breast cancer whose cancer is no longer detectable after treatment before surgery can safely receive less treatment following surgery while maintaining the same strong outcomes, reported OncoDaily and NewsBreak.
New Alliance study aims to improve uptake of genetic testing for colorectal cancer
The new Alliance trial (A212101) led by Frank Sinicrope, MD, of Mayo Clinic, aims to improve the use of genetic testing in colorectal cancer by evaluating strategies to increase germline genetic testing among at-risk family members of newly diagnosed patients, helping to identify individuals who may have inherited cancer risk and could benefit from earlier screening and prevention, reported Yahoo! News, Business Insider, Ad Hoc News, World Pharmaceutical Frontiers, Nasdaq News, Genome Web, and Pulse,
Alliance trial results
ASCO 2026 featured Alliance and Alliance Foundation Trials research
This year’s American Society of Clinical Oncology (ASCO) Annual Meeting featured numerous Alliance and Alliance Foundation Trials abstracts among those selected for presentation. Dozens of new outlets reported that many Alliance trial results presented could change treatment paradigms. They include OncLive, ASCO, Associated Press, The Miami Times, Killeen Daily Herald, First Word Pharma, International Business Times, Benzinga, Stockwatch, Pulse, My Florida News, Investing.com and Yahoo! Finance.
E-News - May 2026
Spotlight on Alliance Research in the News
